Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation
Overview
The purpose of this study is to observe the changes of cardiopulmonary endurance in patients with pacemaker implantation after long-term exercise, to explore the significance of exercise on patients with pacemaker implantation, and to analyze the difference of the effect of exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: None (Open Label)
- Study Primary Completion Date: July 31, 2020
Interventions
- Other: Supervise and guide regular exercise
- Aerobic exercise, evaluated by cardiopulmonary exercise test, 3-5 times a week
Arms, Groups and Cohorts
- Experimental: Regular exercise group
- No Intervention: non-regurlar exercise group
Clinical Trial Outcome Measures
Primary Measures
- Parameters related to exercise cardiopulmonary assessment
- Time Frame: followed up for one year
- VO2peak
Participating in This Clinical Trial
Inclusion Criteria
- 18-75 years old patients with pacemaker implantation for the first time, – 3-6 months after operation – stable condition, – independent walking ability. Exclusion Criteria:
- Cognitive impairment; – ICD, CRT / Crtd implanted, – patients with neurogenic syncope; – Atrial tachycardia, atrial fibrillation, – NYHA class II or above, – difficult to control hypertension; – Musculoskeletal disease limiting activity – nervous system disease, – severe respiratory disease, – Patients with acute inflammation, – cancer and other diseases uncontrolled.
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Peking University Third Hospital
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- lijie sun, MD, Principal Investigator, Peking University Third Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.